Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC ("Cipla Gulf"), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited (BSE: 500087) (NSE: CIPLA EQ; hereafter referred to as "Cipla"), today announced that ...
Biopharmaceutical company Alvotech and Cipla Gulf have entered into an exclusive partnership for the commercialisation of AVT02, an adalimumab biosimilar, in select emerging markets.